Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
Derma X ApS
APS
Active
Advertising protection
CVR 44546841
Amager Strandvej 418, 2770
Kastrup
Wholesale of pharmaceutical and medical goods
·
NACE 4646
Est. 2024 · 2 years old
1 employees
www.derma-x.dk
Monitor
Share
Denmark
/
Companies
/
Wholesale of pharmaceutical and medical goods
/
Derma X ApS
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Gross profit
DKK millions
1M
1M
1M
0M
0M
2025: 1M
1M
2025
EBITDA
DKK millions
1M
1M
1M
0M
0M
2025: 1M
1M
2025
Income statement
DKK thousands
Item
2025
Gross profit
704
Staff expenses
-15
EBITDA
666
Depreciation & amort.
-144
EBIT
522
Net financials
-13
Profit before tax
509
Tax
100
Net profit
409
Balance sheet
DKK thousands
Item
2025
Total assets
891
Equity
449
Long-term debt
0
Short-term debt
442
Total debt
442
Financial ratios
5-year trend
EBITDA margin (of gross profit)
94,6 %
This company
2025
2025
Equity ratio
50,4 %
This company
38,2 %
Market median
This company
Market median
32% above market
2025
2025
Return on equity
91,1 %
This company
18,4 %
Market median
This company
Market median
395% above market
2025
2025
Net profit margin (of gross profit)
58,1 %
This company
2025
2025
Asset turnover (of gross profit)
0,79×
This company
2025
2025
Debt / equity
0,98×
This company
0,62×
Market median
This company
Market median
58% above market
2025
2025
Annual reports & filings
Annual report 2025
Filed via CVR / Virk · Period 2024-01-08 – 2025-06-30
View
PDF
More on Derma X ApS
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
